Press Releases

SYDNEY, July 29, 2025 (GLOBE NEWSWIRE) -- Global broker Axi proudly announces a major milestone in its trader funding program, Axi Select, as it celebrates its 5^th $1 million funded trader, and surpasses $5 million in profit payouts year-to-date.

Effort sets foundation for high-voltage systems,  unlocking breakthrough efficiency and power density

The Precipitated Silica Market Companies Quadrant presents an in-depth analysis of the global precipitated silica market, highlighting top industry players like Evonik Industries AG, Solvay SA, and Tata Chemicals Ltd. With over 40 companies evaluated, the Top 15 emerge as quadrant leaders, driven by innovations, strategic expansions, and a focus on sustainability. The increasing demand across automotive, agriculture, cosmetics, and electronics sectors underscores precipitated silica's versatility. This customizable silicon dioxide improves tire efficiency, supports crop protection, and enhances cosmetic formulations. As industries prioritize sustainability, the role of precipitated silica continues to grow.

Publication du rapport financier du premier semestre 2025 d’Orange

MUNICH, July 29, 2025 (GLOBE NEWSWIRE) -- Meliodays Medical and Celanese Corporation (NYSE: CE) have signed an agreement related to Meliodays’ pre-clinical development of MelioOne^®, the first hormone-free non-contraceptive intrauterine device (IUD) designed to deliver localized relief for menstrual pain. MelioOne^® combines the proven VitalDose^® Drug Delivery Platform from Celanese with Meliodays’ innovative IUD design and non-hormonal active pharmaceutical ingredient (API).

The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leading players like Medtronic and Philips are instrumental in market expansion through innovations and strategic partnerships across Europe.